van der Heijde D.Strand V.Tanaka Y.Keystone E.Kremer J.Zerbini C.A.F.Cardiel M.H.Cohen S.Nash P.Song Y.-W.Tegzová D.Gruben D.Wallenstein G.Connell C.A.Fleischmann R.Hall S.Nicholls D.Rischmueller M.Baker M.F.Bessette L.Cividino A.A.Haraoui B.Niall Jones H.Keystone E.C.Khraishi M.Thorne J.Birbara C.A.Baraf H.S.B.Bathon J.M.Brodsky A.L.Cush J.J.Dikranian A.H.Diri E.Dura P.A.Lohr K.M.Fleischmann R.M.Griffin R.M.Halter D.G.Hargrove J.K.Bouda D.W.Reddy Pasya S.K.Hill G.L.Jackson R.E.Kafka S.P.Kaine J.L.Katzenstein P.L.Kempf K.J.Kolba K.S.Kremer J.M.Longley S.Mathews S.D.Milton A.C.Misischia R.J.Moorman H.A.Moreland L.W.Niemer M.W.Palmer W.R.Sayers M.E.Schuette P.T.Shamim T.Shergy W.J.Sikes D.H.Silverfield J.C.Siva C.Taborn J.D.Walsh B.T.Wells A.F.Wolfe S.M.Adhikari P.Amano K.Bae S.-C.Chandrashekara S.Chopra A.K.PING-NING HSUIwahashi M.Kadel J.K.Kawabe Y.Koh E.-M.Lan J.-L.Lee S.-K.Lin H.-Y.Liou L.-B.Liu M.-F.Migita K.Miyamoto T.Miyasaka N.Mori S.Munakata Y.Ohta S.Park W.Park S.-H.Rao U.R.Shim S.C.Shobha V.Takasaki Y.Takeuchi T.Tanaka Y.Tohma S.Tsai W.-C.Ueki Y.Veeravalli S.C.M.Wagh S.Yamanaka H.Yoo B.Batalov A.Bichoversuska D.Dvorak Z.Goranov I.Hrytsenko H.M.Kopackova J.Mosterova Z.Oparanov B.Petrov A.Pokrzywnicka-Gajek I.Povoroznyuk V.V.Rosa J.Ruzga Z.Settas L.Stanislavchuk M.A.Tseluyko V.I.Vitek P.de Freitas Zerbini C.A.Brenol J.C.T.Cardiel-Rios M.H.Escalante W.J.O.Maldonado-Lopez M.C.Jaller Raad J.J.Hernandez J.D.M.Jauregui E.A.Keiserman M.W.Melazzi A.C.C.Pascual-Ramos V.Pinto L.T.Radominski S.C.Ximenes A.C.de Morales S.V.the ORAL Scan Investigators2021-02-022021-02-0220192326-5191https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065022988&doi=10.1002%2fart.40803&partnerID=40&md5=a3f53c78743fcb00ac3beef4b9212418https://scholars.lib.ntu.edu.tw/handle/123456789/545279[SDGs]SDG3Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four–Month, Phase III Studyjournal article10.1002/art.40803306668262-s2.0-85065022988